IL179171A - Inodolo [b – 3,2] Process for the preparation of quinoxylins converted into alkyl, and pharmaceutical preparations containing them - Google Patents

Inodolo [b – 3,2] Process for the preparation of quinoxylins converted into alkyl, and pharmaceutical preparations containing them

Info

Publication number
IL179171A
IL179171A IL179171A IL17917106A IL179171A IL 179171 A IL179171 A IL 179171A IL 179171 A IL179171 A IL 179171A IL 17917106 A IL17917106 A IL 17917106A IL 179171 A IL179171 A IL 179171A
Authority
IL
Israel
Prior art keywords
formula
indolo
quinoxaline
dimethyl
chloro
Prior art date
Application number
IL179171A
Other languages
English (en)
Hebrew (he)
Other versions
IL179171A0 (en
Original Assignee
Oxypharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxypharma Ab filed Critical Oxypharma Ab
Publication of IL179171A0 publication Critical patent/IL179171A0/en
Publication of IL179171A publication Critical patent/IL179171A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
IL179171A 2004-06-17 2006-11-09 Inodolo [b – 3,2] Process for the preparation of quinoxylins converted into alkyl, and pharmaceutical preparations containing them IL179171A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0401555A SE527639C2 (sv) 2004-06-17 2004-06-17 Alkylsubstituerade indolokinoxaliner
PCT/SE2005/000718 WO2005123741A1 (en) 2004-06-17 2005-05-18 Alkyl substituted indoloquinoxalines

Publications (2)

Publication Number Publication Date
IL179171A0 IL179171A0 (en) 2007-03-08
IL179171A true IL179171A (en) 2012-12-31

Family

ID=32710074

Family Applications (1)

Application Number Title Priority Date Filing Date
IL179171A IL179171A (en) 2004-06-17 2006-11-09 Inodolo [b – 3,2] Process for the preparation of quinoxylins converted into alkyl, and pharmaceutical preparations containing them

Country Status (23)

Country Link
US (2) US7589093B2 (no)
EP (1) EP1756111B1 (no)
JP (1) JP5038891B2 (no)
CN (1) CN1976934B (no)
AT (1) ATE462707T1 (no)
AU (1) AU2005254919B2 (no)
BR (1) BRPI0512086A (no)
CA (1) CA2568592C (no)
CY (1) CY1110145T1 (no)
DE (1) DE602005020283D1 (no)
DK (1) DK1756111T3 (no)
ES (1) ES2342946T3 (no)
IL (1) IL179171A (no)
MX (1) MXPA06014170A (no)
NO (1) NO20070289L (no)
NZ (1) NZ551780A (no)
PL (1) PL1756111T3 (no)
PT (1) PT1756111E (no)
RU (1) RU2369609C2 (no)
SE (1) SE527639C2 (no)
SI (1) SI1756111T1 (no)
WO (1) WO2005123741A1 (no)
ZA (1) ZA200700358B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE529777C2 (sv) * 2006-01-23 2007-11-20 Vironova Ab Nya föreningar och användning därav
JP5454750B2 (ja) 2008-03-05 2014-03-26 東洋製罐株式会社 缶詰の内圧検査方法及びその装置
DE602008001795D1 (de) 2008-04-30 2010-08-26 Univ Duisburg Essen IndolÄ2,3-bÜ-, IndenÄ1,2-bÜ- und IndenÄ2,1-bÜpyridoÄ2,3-fÜ Quinoxalin-3-Carboxylsäuren und Ester, Verfahren zu ihrer Herstellung und ihre Verwendung als Antivirus- und Antitumormittel
EP2489354A1 (en) * 2011-02-18 2012-08-22 Vironova AB Pharmaceutical formulation of B220 for topical treatment of herpes
CN103211960B (zh) * 2012-01-18 2017-10-13 金士力佳友(天津)有限公司 具有降血糖作用的中药组合物、其应用及制备方法
JP2016510798A (ja) * 2013-03-15 2016-04-11 ヴィロノヴァ・ヘルペス・アクチェボラーグ 抗ウイルス性インドロ［２，３−ｂ］キノキサリン
AU2021289006A1 (en) 2020-06-10 2023-02-09 Cyxone Ab Method for preparing a crystalline form of rabeximod
WO2021250196A1 (en) 2020-06-10 2021-12-16 Cyxone Ab New use of rabeximod
WO2022058614A1 (en) 2020-09-21 2022-03-24 Vironova Medical Ab Thionoester-derivative of rabeximod for the treatment of inflammatory and autoimmune disorders
US11643415B1 (en) 2021-12-09 2023-05-09 Cyxone Ab Rabeximod compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504862C2 (sv) * 1994-12-27 1997-05-20 Leif J I Lundblad Användning av vissa indolo-§2,3b¤-kinoxaliner för framställning av ett läkemedel för skydd av DNA i initieringsfasen och/eller promotionsfasen av karcinogenes och för förhindrande av oxidativ stress i patienter med sjukdomar relaterade till fria radikaler
US6333327B2 (en) * 2000-02-18 2001-12-25 Leif J. I. Lundblad Method for the treatment of Multiple Sclerosis
SE516067C2 (sv) * 2000-02-18 2001-11-12 Lundblad Leif J I Användning av en förening för framställning av ett läkemedel

Also Published As

Publication number Publication date
RU2007101497A (ru) 2008-07-27
MXPA06014170A (es) 2007-05-09
US7589093B2 (en) 2009-09-15
WO2005123741A1 (en) 2005-12-29
US8084453B2 (en) 2011-12-27
JP2008502676A (ja) 2008-01-31
SI1756111T1 (sl) 2010-08-31
US20050288296A1 (en) 2005-12-29
AU2005254919A1 (en) 2005-12-29
ES2342946T3 (es) 2010-07-19
CN1976934A (zh) 2007-06-06
ATE462707T1 (de) 2010-04-15
CA2568592C (en) 2012-10-30
EP1756111B1 (en) 2010-03-31
NZ551780A (en) 2010-05-28
JP5038891B2 (ja) 2012-10-03
CA2568592A1 (en) 2005-12-29
IL179171A0 (en) 2007-03-08
ZA200700358B (en) 2008-07-30
PT1756111E (pt) 2010-06-01
PL1756111T3 (pl) 2010-08-31
DK1756111T3 (da) 2010-07-12
EP1756111A1 (en) 2007-02-28
SE527639C2 (sv) 2006-05-02
DE602005020283D1 (de) 2010-05-12
US20110086859A9 (en) 2011-04-14
NO20070289L (no) 2007-01-16
SE0401555D0 (sv) 2004-06-17
RU2369609C2 (ru) 2009-10-10
BRPI0512086A (pt) 2008-02-06
SE0401555L (sv) 2005-12-18
CY1110145T1 (el) 2015-01-14
AU2005254919B2 (en) 2011-07-21
US20100009999A1 (en) 2010-01-14
CN1976934B (zh) 2013-05-29

Similar Documents

Publication Publication Date Title
IL179171A (en) Inodolo [b – 3,2] Process for the preparation of quinoxylins converted into alkyl, and pharmaceutical preparations containing them
US4996206A (en) N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives
AU716993B2 (en) Novel deazapurine derivatives; a new class of CRF1 specific ligands
SAYED MOHAMED et al. Synthesis of certain pyrrole derivatives as antimicrobial agents
RU2010117156A (ru) Гетероциклические соединения в качестве антагонистов crth2 рецептора
CA2556946A1 (en) Pyrrolopyrimidine derivatives
RU2009115963A (ru) Производные оксадиазола, обладающие противовоспалительными и иммунодепрессантными свойствами
CA2628131A1 (en) Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
ZA200401365B (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments.
RU2014141579A (ru) Гетероциклические соединения в качестве ингибиторов бета-лактамаз
HRP20100670T1 (hr) Aril-supstituirani pirazol-amid spojevi korisni kao inhibitori kinaze
WO2009098715A4 (en) Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
KR20210025016A (ko) 접합 삼중고리형 헤테로사이클 화합물과 그 치료 용도
HRP20130918T1 (hr) Derivati 4-aminopirimidina kao receptori antagonista histamina h4
RU2007123251A (ru) Производные хромана и их применение в качестве лигандов 5-нт рецептора
ES2282986T3 (es) Derivados de triaza-ciclopenta(cd)indeno.
NZ504657A (en) Reacting 8-halogeno-quinolonecarboxylic acid derivatives with alkanols or benzyl alcohol
ES2554933T3 (es) Procedimiento de síntesis y forma cristalina de clorhidrato de 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1H)-il]propoxi}benzamida, así como la base libre asociada y las composiciones farmacéuticas que los contienen
WO2008003858A3 (fr) Utilisation de dérivés d'imidazo[1, 2-a]pyridine-2-carboxamides en thérapeutique
RU2006141393A (ru) Производные 7н-пиррол[2,3-d]пиримидина, их фармацевтически приемлемые соли, содержащие их фармацевтические композиции и способ их получения
JP2007534737A5 (no)
CA2435958A1 (en) Pyrimidine compounds and methods for making and using the same
FR2856063B1 (fr) Procede de preparation du cis-8b-methyldecahydro-2a,4a,6a, 8a-tetraazacyclopenta[fg]acenaphthylene,ou du cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg] acenaphthylene, du cyclene, et de cyclenes fonctionnalises
PL91741B1 (no)

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees